
TY  - JOUR
TI  - Poster abstracts
JO  - American Journal of Transplantation
VL  - 10
IS  - s4
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2010.03108.x
DO  - doi:10.1111/j.1600-6143.2010.03108.x
SP  - 213
EP  - 571
PY  - 2010
ER  - 

TY  - JOUR
TI  - 2009 International BioIron Society Meeting
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 84
IS  - 8
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21464
DO  - doi:10.1002/ajh.21464
SP  - E236
EP  - E375
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 20
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.1197
DO  - doi:10.1002/ejhf.1197
SP  - 5
EP  - 638
PY  - 2018
ER  - 

TY  - JOUR
TI  - 2019 Annual Meeting of the American Society for Bone and Mineral Research Orange County Convention Center, Orlando, Florida, USA September 20–23, 2019
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 34
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.3936
DO  - doi:10.1002/jbmr.3936
SP  - S1
EP  - S442
PY  - 2019
ER  - 

TY  - JOUR
TI  - Moderated Poster
JO  - International Journal of Urology
JA  - Int. J. Urol.
VL  - 25
IS  - S1
SN  - 0919-8172
UR  - https://doi.org/10.1111/iju.13751
DO  - doi:10.1111/iju.13751
SP  - 245
EP  - 375
PY  - 2018
ER  - 

TY  - JOUR
TI  - Posters
JO  - Transplant International
JA  - Transpl Int
VL  - 28
IS  - S4
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12702
DO  - doi:10.1111/tri.12702
SP  - 277
EP  - 846
PY  - 2015
ER  - 

TY  - JOUR
TI  - GLIA Edinburgh 2017: Abstracts Oral Presentations, Posters, Indexes
JO  - Glia
JA  - Glia
VL  - 65
IS  - S1
SN  - 0894-1491
UR  - https://doi.org/10.1002/glia.23157
DO  - doi:10.1002/glia.23157
SP  - E103
EP  - E578
PY  - 2017
ER  - 

TY  - JOUR
AU  - McKinlay, J.
AU  - Tyson, E.
AU  - Forni, L. G.
TI  - Renal complications of anaesthesia
JO  - Anaesthesia
JA  - Anaesthesia
VL  - 73
IS  - S1
SN  - 0003-2409
UR  - https://doi.org/10.1111/anae.14144
DO  - doi:10.1111/anae.14144
SP  - 85
EP  - 94
KW  - acute kidney injury (AKI)
KW  - risk factors
KW  - peri-operative management
KW  - nephrotoxins
PY  - 2018
AB  - Summary Peri-operative acute kidney injury is common, accounting for 30?40% of all in-hospital cases of acute kidney injury. It is associated with clinically significant morbidity and mortality even with what was hitherto regarded as relatively trivial increases in serum creatinine, and carries over a 12-fold relative risk of death following major abdominal surgery. Comorbid conditions such as diabetes, hypertension, liver disease and particularly pre-existing chronic kidney disease, as well as the type and urgency of surgery, are major risk factors for the development of postoperative acute kidney injury. As yet, there are no specific treatment options for the injured kidney, although there are several modifiable risk factors of which the anaesthetist should be aware. As well as the avoidance of potential nephrotoxins and appropriate volume balance, optimal anaesthetic management should aim to reduce the risk of postoperative renal complications. This may include careful ventilatory management and blood pressure control, as well as appropriate analgesic strategies. The choice of anaesthetic agent may also influence renal outcomes. Rather than concentrate on the classical management of acute kidney injury, this review focuses on the potential development of acute kidney injury peri-operatively, and the means by which this may be ameliorated.
ER  - 

TY  - JOUR
AU  - He, Tianlin
C7  - 1800198
TI  - Implementation of Proteomics in Clinical Trials
JO  - PROTEOMICS – Clinical Applications
JA  - Prot. Clin. Appl.
VL  - 13
IS  - 2
SN  - 1862-8346
UR  - https://doi.org/10.1002/prca.201800198
DO  - doi:10.1002/prca.201800198
SP  - 1800198
KW  - clinical trials
KW  - diagnosis
KW  - prognosis
KW  - proteomic/protein assays
KW  - stratification
PY  - 2019
AB  - Abstract The application of protein (or peptide) biomarkers in clinical studies is a dynamic, ever-growing field. The introduction of clinical proteomics/peptidomics, such as mass spectrometry?based assays and multiplexed antibody?based protein arrays, has reshaped the landscape of biomarker identification and validation, allowing the discovery of novel biomarkers at an unprecedented rate and reliability. To reflect the current status with respect to implementation of protein/peptide biomarkers, an investigation of the most recent (last 6 years) clinical studies from clinicaltrials.gov is presented. Forty-two clinical trials involving the direct use of protein or peptide biomarkers in patient stratification and/or disease diagnosis and prognosis are highlighted. Most of the clinical trials that include proteomics/protein assays are aiming toward implementation of non-invasive diagnostic tools for early detection, while many of the clinical trials are targeting to correlate the protein abundance with the risk of a disease event. Less in number are the studies in which the protein biomarkers are applied to stratify the patients for intervention. All the above areas of application are considered of great importance for improving disease management, in an era where implementation toward precision medicine is the desired outcome of proteomics biomarker research.
ER  - 

TY  - JOUR
TI  - Poster Session TPS
JO  - Allergy
JA  - Allergy
VL  - 72
IS  - S103
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.13252
DO  - doi:10.1111/all.13252
SP  - 383
EP  - 757
PY  - 2017
ER  - 

AU  - Dieterle, Frank
AU  - Sistare, Frank D.
C7  - pp. 237-279
TI  - Biomarkers of Acute Kidney Injury
SN  - 9780470452240
UR  - https://doi.org/10.1002/9780470918562.ch10
DO  - doi:10.1002/9780470918562.ch10
SP  - 237-279
KW  - acute kidney injury
KW  - kidney safety biomarkers
KW  - functional biomarkers
KW  - leakage markers
KW  - expression markers
PY  - 2017
AB  - Summary This chapter contains sections titled: Introduction Novel Kidney Safety Biomarkers Newest Technologies and Achievements Around Kidney Safety Biomarkers Conclusion Summary Points
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - American Journal of Transplantation
VL  - 5
IS  - s11
SN  - 9780470452240
UR  - https://doi.org/10.1111/j.1600-6135.2005.abstracts.x
DO  - doi:10.1111/j.1600-6135.2005.abstracts.x
SP  - 155
EP  - 576
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 16
IS  - s1
SN  - 9780470452240
UR  - https://doi.org/10.1002/ejhf.77
DO  - doi:10.1002/ejhf.77
SP  - 1
EP  - 41
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts Poster
JO  - American Journal of Transplantation
VL  - 9
IS  - s2
SN  - 9780470452240
UR  - https://doi.org/10.1111/j.1600-6143.2009.02659.x
DO  - doi:10.1111/j.1600-6143.2009.02659.x
SP  - 384
EP  - 729
PY  - 2009
ER  - 

TY  - JOUR
TI  - Posters
JO  - Transplant International
JA  - Transpl Int
VL  - 26
IS  - s2
SN  - 9780470452240
UR  - https://doi.org/10.1111/tri.12214
DO  - doi:10.1111/tri.12214
SP  - 185
EP  - 339
PY  - 2013
ER  - 

TY  - JOUR
TI  - SARS abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 104
IS  - S3
SN  - 9780470452240
UR  - https://doi.org/10.1002/bjs.10531
DO  - doi:10.1002/bjs.10531
SP  - 7
EP  - 57
PY  - 2017
ER  - 

TY  - JOUR
TI  - European Society for Veterinary Clinical Pathology (ESVCP) 13th Annual Congress
JO  - Veterinary Clinical Pathology
JA  - Vet Clin Pathol
VL  - 41
IS  - 1
SN  - 9780470452240
UR  - https://doi.org/10.1111/j.1939-165X.2011.00375.x
DO  - doi:10.1111/j.1939-165X.2011.00375.x
SP  - E1
EP  - E16
PY  - 2012
ER  - 

TY  - JOUR
AU  - Ricchetti, Alma
AU  - Burkhard, Pierre R.
AU  - Rodrigo, Neftali
AU  - Gamulin, Zdravko
AU  - Côte, Mélanie
AU  - Reverdin, Alain
AU  - Trussart, Catherine
AU  - Landis, Basile N.
AU  - Lacroix, Jean-Silvain
TI  - Skull base cerebrospinal fluid fistula: a novel detection method based on two-dimensional electrophoresis
JO  - Head & Neck
JA  - Head Neck
VL  - 26
IS  - 5
SN  - 9780470452240
UR  - https://doi.org/10.1002/hed.10359
DO  - doi:10.1002/hed.10359
SP  - 464
EP  - 469
KW  - rhinorrhea
KW  - cerebrospinal fluid (CSF)
KW  - nasal mucus
KW  - blood
KW  - two-dimensional electrophoresis (2-DE)
PY  - 2004
AB  - Abstract Due to a processing error, this manuscript was inadvertently published online in Head & Neck on January 16, 2004, without Table 1. The publisher has replaced the incorrect version of the published article with the correct version containing Table 1. For archival purposes, the earlier version is available by contacting the publisher at headandneck@wiley.com. This should be considered the definitive version of this article. Background. The detection of the presence of cerebrospinal fluid (CSF) in nasal secretions contaminated with blood and mucus remains a challenging clinical problem. Methods. A prospective study was conducted from November 1998 to February 2002, including 42 patients. Samples (250 ?L) of nasal secretions were analyzed by two-dimensional electrophoresis (2-DE). Plasma, mucus, and CSF were identified by specific proteins markers corresponding to characteristic trains of spots. Intrathecal injection of fluorescein followed by the detection of fluorescein on endoscopic examination of the nasal cavities was considered a positive reference for CSF rhinorrhea. Results. In all cases of positive fluorescein test, we unambiguously observed the presence of several specific CSF markers onto the 2-DE gels. Conversely, all negative fluorescein tests were associated with the absence of CSF-specific spots. Conclusions. Two-DE analyses of biologic fluids of nasal origin should be considered as a reliable diagnostic tool in case of suspicion of CSF leak. ? 2003 Wiley Periodicals, Inc. Head Neck 25: 464?469, 2003
ER  - 

TY  - JOUR
AU  - Herold, Kristina
AU  - Mrowka, Ralf
C7  - e13284
TI  - Inflammation—Dysregulated inflammatory response and strategies for treatment
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 226
IS  - 3
SN  - 9780470452240
UR  - https://doi.org/10.1111/apha.13284
DO  - doi:10.1111/apha.13284
SP  - e13284
PY  - 2019
ER  - 

TY  - JOUR
TI  - Plenary Lectures and Plenary Debate
JO  - International Journal of Andrology
VL  - 28
IS  - s1
SN  - 9780470452240
UR  - https://doi.org/10.1111/j.1365-2605.2005.00551_1.x
DO  - doi:10.1111/j.1365-2605.2005.00551_1.x
SP  - 1
EP  - 3
PY  - 2005
ER  - 
